- advocacy
- anti-nephrin autoantibodies
- APOL1
- awards
- basic and translational research
- clinical trials
- education
- events
- fellowship
- FSGS
- genetics
- H3Africa
- health equity
- idiopathic nephrotic syndrome
- membranous nephropathy
- minimal change disease
- nephrotic syndrome
- new era act
- parasol
- PLA2R
- podocyte conference
- preceptorship
- publications
- research funding
Day 2: PARASOL APOL1 & MN Kickoff
The October 10 sessions of the PARASOL kickoff meeting for APOL1 kidney disease and ...
Day 1 Highlights: PARASOL APOL1 & MN Kickoff
The PARASOL APOL1 and MN kickoff meeting in Minneapolis on October 9, 2025 convened ...
PARASOL Project Expands Focus to APOL1, Membranous Nephropathy
The organizing committee of PARASOL (PROTEINURIA AND OTHER BIOMARKERS AS ENDPOINTS FOR ...
PARASOL Project Advances Understanding of Proteinuria in FSGS
BETHESDA, Md. October 14, 2024 – A multi-stakeholder group of rare kidney disease experts ...
PARASOL Interim Meeting Report
After a successful meeting in December 2023 to launch the PARASOL initiative, the group ...
FSGS and NS Research Funding Opportunities Through PRMRP
The US Department of Defense includes FSGS and nephrotic syndrome as two of the priority ...
New Era Act Introduced in Congress
We are thrilled to share that the New Era of Preventing End-Stage Kidney Disease Act ...
Announcing the PARASOL Project: PROTEINURIA AND GFR AS CLINICAL TRIAL ENDPOINTS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS
ISGD is collaborating in a multidisciplinary effort to tackle the urgent problem of ...
The AFFINITY Study: Seeking 20 FSGS Patients
The AFFINITY study is a global, open-label, phase 2 basket trial evaluating the safety ...